Ontology highlight
ABSTRACT:
SUBMITTER: Ghelli Luserna Di Rora A
PROVIDER: S-EPMC5288194 | biostudies-literature | 2016 Aug
REPOSITORIES: biostudies-literature
Ghelli Luserna Di Rorà Andrea A Iacobucci Ilaria I Imbrogno Enrica E Papayannidis Cristina C Derenzini Enrico E Ferrari Anna A Guadagnuolo Viviana V Robustelli Valentina V Parisi Sarah S Sartor Chiara C Abbenante Maria Chiara MC Paolini Stefania S Martinelli Giovanni G
Oncotarget 20160801 33
During the last few years many Checkpoint kinase 1/2 (Chk1/Chk2) inhibitors have been developed for the treatment of different type of cancers. In this study we evaluated the efficacy of the Chk 1/2 inhibitor prexasertib mesylate monohydrate in B-/T- cell progenitor acute lymphoblastic leukemia (ALL) as single agent and in combination with other drugs. The prexasertib reduced the cell viability in a dose and time dependent manner in all the treated cell lines. The cytotoxic activity was confirme ...[more]